BioSpace News Archive

Press Releases

Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results

November 19, 2024
·
13 min read
Press Releases

Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs

November 19, 2024
·
2 min read
Press Releases

Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra (JNJ-2113) in Plaque Psoriasis, a First-in-Class Investigational Targeted Oral Peptide That Selectively Blocks the IL-23 Receptor

November 19, 2024
·
8 min read
Press Releases

Neurogene Reports Third Quarter 2024 Financial Results and Highlights Recent Updates

November 19, 2024
·
11 min read
Press Releases

TrueBinding Receives FDA IND Go Ahead for Parkinson’s Phase 2A Clinical Trial

November 19, 2024
·
6 min read
Press Releases

Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member

November 19, 2024
·
5 min read
Press Releases

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling

November 19, 2024
·
5 min read
Press Releases

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

November 19, 2024
·
8 min read
Press Releases

Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024

November 19, 2024
·
4 min read
Press Releases

Telix to Add FAP-Targeting Candidates to Theranostic Pipeline

November 19, 2024
·
8 min read